Organogenesis Holdings Inc (ORGO)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $104.24M
Last updated: Nov 17, 2026 at 4:10 PM ET
Organogenesis Holdings Inc (ORGO) Stock Chart
Organogenesis Holdings (ORGO) has a latest price of $0.81 on Nov 17, 2026, 86.3% below its 52-week high of $5.91. Its price fell 86.7% over the past 12 months. The month-end price fell 92.2% since Jan 2017, a compound annual decline of 23.0%.
Price Chart
From Jan 2017 to Oct 2026, its highest month-end close was $22.36 in Apr 2021 and its lowest $0.77 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ORGO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ORGO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 57.5%, and over 6 months it fell 66.6%. The month-end price fell 65.7% over the 3 years through Oct 2026, a compound annual decline of 30.0%.
| Period | Change |
|---|---|
| 1 month | -20.4% |
| 3 months | -57.5% |
| 6 months | -66.6% |
| 12 months | -86.7% |
| 12 months, with dividends | -86.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -65.7% | -30.0% |
| 5 years | -93.0% | -41.3% |
| Since Jan 2017 | -92.2% | -23.0% |
Price by Year
Its best calendar year was 2025, when the price rose 61.9%, and its weakest was 2022, when it fell 70.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.77 | -85.2% |
| 2025 | $5.18 | +61.9% |
| 2024 | $3.20 | -21.8% |
| 2023 | $4.09 | +52.0% |
| 2022 | $2.69 | -70.9% |
| 2021 | $9.24 | +22.7% |
| 2020 | $7.53 | +56.5% |
| 2019 | $4.81 | -52.6% |
| 2018 | $10.15 | +2.3% |
Trading Range
The price is 29.6% below its 50-day average of $1.15 and 62.9% below its 200-day average of $2.19.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.81 | |
| 52-week high | $5.91 | -86.3% |
| 52-week low | $0.73 | +11.2% |
| 50-day average | $1.15 | -29.6% |
| 200-day average | $2.19 | -62.9% |
Price Risk
Over 3 years, its largest fall from a peak was 88.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.23 |
| Largest fall, 1 year | -87.4% |
| Largest fall, 3 years | -88.5% |
Valuation
Organogenesis Holdings traded at 17.9x earnings at the end of 2025, against a 5-year median of 21.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ORGO
What is ORGO's 1-year price change?
Organogenesis Holdings's price fell 86.7% over the past 12 months. With dividends included, the 12-month total return was -86.7%.
What is ORGO's 5-year price change?
Organogenesis Holdings's month-end price fell 93.0% over the 5 years through Oct 2026, a compound annual decline of 41.3%. These figures leave out dividends.
What is ORGO's 52-week high and low?
Organogenesis Holdings's 52-week high is $5.91 and its 52-week low is $0.73. Its latest price of $0.81 on Nov 17, 2026 is 86.3% below the high.
What is ORGO's beta?
Organogenesis Holdings's 1-year beta against the S&P 500 is 1.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.4%.
Is the ORGO chart free?
Yes. Advanced Charting for ORGO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ORGO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts